PT3150222T - Composições imunogénicas estáveis de antigénios de staphylococcus aureus - Google Patents
Composições imunogénicas estáveis de antigénios de staphylococcus aureusInfo
- Publication number
- PT3150222T PT3150222T PT161930953T PT16193095T PT3150222T PT 3150222 T PT3150222 T PT 3150222T PT 161930953 T PT161930953 T PT 161930953T PT 16193095 T PT16193095 T PT 16193095T PT 3150222 T PT3150222 T PT 3150222T
- Authority
- PT
- Portugal
- Prior art keywords
- staphylococcus aureus
- immunogenic compositions
- aureus antigens
- stable immunogenic
- stable
- Prior art date
Links
- 241000191967 Staphylococcus aureus Species 0.000 title 1
- 239000000427 antigen Substances 0.000 title 1
- 102000036639 antigens Human genes 0.000 title 1
- 108091007433 antigens Proteins 0.000 title 1
- 230000002163 immunogen Effects 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/085—Staphylococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- General Chemical & Material Sciences (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201061426476P | 2010-12-22 | 2010-12-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT3150222T true PT3150222T (pt) | 2020-02-03 |
Family
ID=45444677
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT161930953T PT3150222T (pt) | 2010-12-22 | 2011-12-21 | Composições imunogénicas estáveis de antigénios de staphylococcus aureus |
| PT118048222T PT2654784T (pt) | 2010-12-22 | 2011-12-21 | Composições imunogénicas estáveis de antigénios de staphylococcus aureus |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT118048222T PT2654784T (pt) | 2010-12-22 | 2011-12-21 | Composições imunogénicas estáveis de antigénios de staphylococcus aureus |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US20130259896A1 (enExample) |
| EP (2) | EP2654784B1 (enExample) |
| JP (1) | JP6097478B2 (enExample) |
| KR (2) | KR20130114210A (enExample) |
| CN (1) | CN103826656B (enExample) |
| AU (1) | AU2011346535B2 (enExample) |
| BR (1) | BR112013016153A2 (enExample) |
| CA (1) | CA2819120C (enExample) |
| DK (2) | DK2654784T3 (enExample) |
| ES (2) | ES2614815T3 (enExample) |
| HU (2) | HUE047263T2 (enExample) |
| IL (1) | IL226793B (enExample) |
| MX (1) | MX350170B (enExample) |
| PL (2) | PL2654784T3 (enExample) |
| PT (2) | PT3150222T (enExample) |
| RU (1) | RU2570730C2 (enExample) |
| SI (2) | SI3150222T1 (enExample) |
| WO (1) | WO2012085872A2 (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2540770T3 (es) | 2004-09-22 | 2015-07-13 | Glaxosmithkline Biologicals Sa | Composición inmunógena para uso en vacunación contra estafilococos |
| SG10201406432RA (en) | 2009-06-22 | 2014-11-27 | Wyeth Llc | Compositions and methods for preparing staphylococcus aureus serotype 5 and 8 capsular polysaccharide conjugate immunogenic compositions |
| HUE036372T2 (hu) | 2009-06-22 | 2018-07-30 | Wyeth Llc | Staphylococcus aureus antigének immunogén készítményei |
| US9095567B2 (en) * | 2010-06-04 | 2015-08-04 | Wyeth Llc | Vaccine formulations |
| EP2686010A2 (en) * | 2011-03-16 | 2014-01-22 | Regents of the University of Minnesota | Compositions and methods for inducing immune responses against bacteria in the genus staphylococcus |
| GB201310008D0 (en) * | 2013-06-05 | 2013-07-17 | Glaxosmithkline Biolog Sa | Immunogenic composition for use in therapy |
| MX370488B (es) * | 2013-12-04 | 2019-12-16 | Glaxosmithkline Biologicals Sa | Prevencion de infecciones por staphylococcus aureus mediante vacunas de glucoproteina sintetizadas en escherichia coli. |
| IL310015B1 (en) * | 2013-12-31 | 2025-10-01 | Access To Advanced Health Inst | Single vial formulation |
| EP3129001B1 (en) * | 2014-04-10 | 2019-10-02 | ASIT BioTech s.a. | Hsp-free allergen preparation |
| KR20200040812A (ko) * | 2017-08-16 | 2020-04-20 | 머크 샤프 앤드 돔 코포레이션 | 폐렴구균 접합체 백신 제제 |
| GB201802339D0 (en) | 2018-02-13 | 2018-03-28 | Glaxosmithkline Biologicals Sa | Immunogenic composition |
| KR102649069B1 (ko) | 2018-05-31 | 2024-03-19 | 주식회사 엑소코바이오 | 줄기세포 유래의 엑소좀을 유효성분으로 포함하는 안면 홍조 개선용 조성물 |
| KR102058961B1 (ko) * | 2018-07-28 | 2019-12-24 | 주식회사 엑소코바이오 | 엑소좀의 동결건조 방법 |
| KR102163806B1 (ko) | 2018-07-30 | 2020-10-07 | 주식회사 엑소코바이오 | 줄기세포 유래의 엑소좀을 유효성분으로 포함하는 피지분비 감소용 조성물 |
| IL294461A (en) * | 2020-01-13 | 2022-09-01 | Aptevo Res & Development Llc | Methods and compositions for preventing adsorption of therapeutic proteins to drug delivery system components |
Family Cites Families (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4902506A (en) | 1983-07-05 | 1990-02-20 | The University Of Rochester | Immunogenic conjugates |
| US4673574A (en) | 1981-08-31 | 1987-06-16 | Anderson Porter W | Immunogenic conjugates |
| US4708871A (en) | 1983-03-08 | 1987-11-24 | Commonwealth Serum Laboratories Commission | Antigenically active amino acid sequences |
| SE8405493D0 (sv) | 1984-11-01 | 1984-11-01 | Bror Morein | Immunogent komplex samt sett for framstellning derav och anvendning derav som immunstimulerande medel |
| US5078996A (en) | 1985-08-16 | 1992-01-07 | Immunex Corporation | Activation of macrophage tumoricidal activity by granulocyte-macrophage colony stimulating factor |
| US5057540A (en) | 1987-05-29 | 1991-10-15 | Cambridge Biotech Corporation | Saponin adjuvant |
| US4912094B1 (en) | 1988-06-29 | 1994-02-15 | Ribi Immunochem Research Inc. | Modified lipopolysaccharides and process of preparation |
| JPH0832638B2 (ja) | 1989-05-25 | 1996-03-29 | カイロン コーポレイション | サブミクロン油滴乳剤を含んで成るアジュバント製剤 |
| IT1253009B (it) | 1991-12-31 | 1995-07-10 | Sclavo Ricerca S R L | Mutanti immunogenici detossificati della tossina colerica e della tossina lt, loro preparazione ed uso per la preparazione di vaccini |
| US5571515A (en) | 1994-04-18 | 1996-11-05 | The Wistar Institute Of Anatomy & Biology | Compositions and methods for use of IL-12 as an adjuvant |
| US6207646B1 (en) | 1994-07-15 | 2001-03-27 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules |
| US6008341A (en) | 1994-08-22 | 1999-12-28 | The Provost, Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth Near Dublin | S. aureus fibrinogen binding protein gene |
| BE1008978A5 (fr) | 1994-12-27 | 1996-10-01 | Solvay | Adjuvants pour vaccins. |
| US5700928A (en) | 1995-10-16 | 1997-12-23 | Smithkline Beecham, P.L.C. | Polynucleotide encoding saliva binding protein |
| GB9622159D0 (en) | 1996-10-24 | 1996-12-18 | Solvay Sociutu Anonyme | Polyanionic polymers as adjuvants for mucosal immunization |
| GB9622660D0 (en) | 1996-10-31 | 1997-01-08 | Biocine Spa | Immunogenic detoxified mutant toxin |
| US6113918A (en) | 1997-05-08 | 2000-09-05 | Ribi Immunochem Research, Inc. | Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors |
| EP1034277B1 (en) | 1997-11-26 | 2012-06-27 | Inhibitex, Inc. | Extracellular matrix-binding proteins from Staphylococcus aureus |
| US6680195B1 (en) | 1997-11-26 | 2004-01-20 | Inhibitex, Inc. | Extracellular matrix-binding proteins from staphylococcus aureus |
| CN1314450C (zh) * | 1998-08-31 | 2007-05-09 | 英希比泰克斯公司 | 多组分疫苗 |
| US6936258B1 (en) | 1999-03-19 | 2005-08-30 | Nabi Biopharmaceuticals | Staphylococcus antigen and vaccine |
| US7115730B1 (en) | 1999-04-27 | 2006-10-03 | Chiron Srl | Immunogenic detoxified mutant E. coli LT-A-toxin |
| US7384640B1 (en) | 1999-09-30 | 2008-06-10 | Wyeth Holdings Corporation | Mutant cholera holotoxin as an adjuvant |
| CZ304195B6 (cs) | 2000-06-08 | 2013-12-27 | Intercell Ag | Imunostimulační farmaceutický přípravek |
| AT410635B (de) | 2000-10-18 | 2003-06-25 | Cistem Biotechnologies Gmbh | Vakzin-zusammensetzung |
| WO2002098368A2 (en) | 2001-06-07 | 2002-12-12 | Wyeth Holdings Corporation | Mutant forms of cholera holotoxin as an adjuvant |
| AU2002322380B2 (en) | 2001-06-07 | 2006-11-02 | Government Of The United States Of America As Represented By The Uniformed Services University Of The Health Sciences | Mutant forms of cholera holotoxin as an adjuvant |
| EP1423701B1 (en) | 2001-06-15 | 2012-07-25 | Inhibitex, Inc. | Cross-reactive monoclonal and polyclonal antibodies which recognize surface proteins from coagulase-negative staphylococci and staphylococcus aureus |
| GB0118249D0 (en) | 2001-07-26 | 2001-09-19 | Chiron Spa | Histidine vaccines |
| JP5102487B2 (ja) | 2003-03-07 | 2012-12-19 | ワイス・ホールディングズ・コーポレイション | 院内感染に対する免疫化のための多糖ブドウ球菌表面付着因子キャリアタンパク質接合体 |
| EP1603950A2 (en) | 2003-03-17 | 2005-12-14 | Wyeth Holdings Corporation | Mutant cholera holotoxin as an adjuvant and an antigen carrier protein |
| GB0323103D0 (en) | 2003-10-02 | 2003-11-05 | Chiron Srl | De-acetylated saccharides |
| ES2540770T3 (es) * | 2004-09-22 | 2015-07-13 | Glaxosmithkline Biologicals Sa | Composición inmunógena para uso en vacunación contra estafilococos |
| AR060187A1 (es) * | 2006-03-30 | 2008-05-28 | Glaxosmithkline Biolog Sa | Composicion inmunogenica |
| EA020459B1 (ru) * | 2006-03-30 | 2014-11-28 | Глаксосмитклайн Байолоджикалс С.А. | Иммуногенная композиция |
| GB0606416D0 (en) * | 2006-03-30 | 2006-05-10 | Glaxosmithkline Biolog Sa | Immunogenic composition |
| US20070253985A1 (en) | 2006-04-26 | 2007-11-01 | Wyeth | Novel processes for coating container means which inhibit precipitation of polysaccharide-protein conjugate formulations |
| MX2009004862A (es) * | 2006-11-07 | 2009-07-17 | Sanofi Pasteur Biologics Co | Estabilizacion de vacunas por liofilizacion. |
| AU2009221180B2 (en) | 2008-03-05 | 2014-02-13 | Sanofi Pasteur | Process for stabilizing an adjuvant containing vaccine composition |
| HUE036372T2 (hu) * | 2009-06-22 | 2018-07-30 | Wyeth Llc | Staphylococcus aureus antigének immunogén készítményei |
-
2011
- 2011-12-21 PL PL11804822T patent/PL2654784T3/pl unknown
- 2011-12-21 SI SI201131825T patent/SI3150222T1/sl unknown
- 2011-12-21 RU RU2013128277/15A patent/RU2570730C2/ru active IP Right Revival
- 2011-12-21 ES ES11804822.2T patent/ES2614815T3/es active Active
- 2011-12-21 CA CA2819120A patent/CA2819120C/en active Active
- 2011-12-21 WO PCT/IB2011/055883 patent/WO2012085872A2/en not_active Ceased
- 2011-12-21 SI SI201131064A patent/SI2654784T1/sl unknown
- 2011-12-21 EP EP11804822.2A patent/EP2654784B1/en active Active
- 2011-12-21 EP EP16193095.3A patent/EP3150222B1/en active Active
- 2011-12-21 PT PT161930953T patent/PT3150222T/pt unknown
- 2011-12-21 CN CN201180068105.5A patent/CN103826656B/zh not_active Expired - Fee Related
- 2011-12-21 MX MX2013006960A patent/MX350170B/es active IP Right Grant
- 2011-12-21 HU HUE16193095A patent/HUE047263T2/hu unknown
- 2011-12-21 KR KR1020137018851A patent/KR20130114210A/ko not_active Ceased
- 2011-12-21 AU AU2011346535A patent/AU2011346535B2/en not_active Ceased
- 2011-12-21 DK DK11804822.2T patent/DK2654784T3/en active
- 2011-12-21 KR KR1020157031951A patent/KR101808398B1/ko not_active Expired - Fee Related
- 2011-12-21 BR BR112013016153A patent/BR112013016153A2/pt not_active Application Discontinuation
- 2011-12-21 PT PT118048222T patent/PT2654784T/pt unknown
- 2011-12-21 HU HUE11804822A patent/HUE033072T2/hu unknown
- 2011-12-21 PL PL16193095T patent/PL3150222T3/pl unknown
- 2011-12-21 US US13/993,887 patent/US20130259896A1/en not_active Abandoned
- 2011-12-21 DK DK16193095.3T patent/DK3150222T3/da active
- 2011-12-21 ES ES16193095T patent/ES2769425T3/es active Active
- 2011-12-22 JP JP2011280781A patent/JP6097478B2/ja not_active Expired - Fee Related
-
2013
- 2013-06-06 IL IL226793A patent/IL226793B/en active IP Right Grant
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG10201707084SA (en) | Immunogenic compositions of staphylococcus aureus antigens | |
| IL226793B (en) | Stable immunogenic compositions of staphylococcus aureus antigens | |
| ZA202002470B (en) | Staphylococcus aureus leukocidins, therapeutic compositions, and uses thereof | |
| IL231104A0 (en) | Helper assemblies of antigens for Staphylococcus aureus | |
| AP3445A (en) | Pesticidal compositions | |
| EP2549993A4 (en) | ANTIMICROBIAL COMPOSITIONS | |
| ZA201403788B (en) | Stable pesticidal compositions | |
| ZA201300073B (en) | Compositions comprising optical benefit agents | |
| AP2013006769A0 (en) | Pesticidal compositions | |
| BR112013017664A2 (pt) | composições de pó de cacau | |
| GB201015132D0 (en) | Vaccine composition | |
| IL238328A0 (en) | Stable preparations that include peracetic acid | |
| PL2768936T3 (pl) | Preparaty, ich zastosowanie jako środków do zmywania naczyń lub do wytwarzania środków do zmywania naczyń i ich wytwarzanie | |
| EP2605654A4 (en) | ANTIMICROBIAL COMPOSITIONS | |
| PL2407155T3 (pl) | Formulacje inekalcytolu | |
| ZA201301908B (en) | Immunogenic compositions | |
| GB201003799D0 (en) | Antimicrobial compositions | |
| GB201002594D0 (en) | Antimicrobial compositions | |
| GB201010944D0 (en) | Antimicrobial compositions | |
| GB201013150D0 (en) | Antimicrobial compositions | |
| GB201111128D0 (en) | Antimicrobial compositions | |
| AU2012900227A0 (en) | Compositions of nimorazole | |
| GB201005587D0 (en) | Novel formulations |